Patients' Experiences and Perceptions of 3TC/DTG Dual Therapy (the PEDAL Study) (PEDAL)
Lamivudine (3TC) Plus Dolutegravir (DTG) Dual Therapy: a Study on Patients' Experiences and Perceptions
Sponsor: Brighton and Sussex University Hospitals NHS Trust
A observational or N/A phase clinical study on HIV Infections, this trial is ongoing. The trial is conducted by Brighton and Sussex University Hospitals NHS Trust and has accumulated 6 data snapshots since 2021. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Jun 2024 — Jul 2024 [monthly]
Unknown Status
Status: Active Not Recruiting → Unknown Status
-
Jun 2022 — Jun 2024 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Sep 2021 — Jun 2022 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
▶ Show 1 earlier version
-
Jun 2021 — Sep 2021 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Brighton and Sussex University Hospitals NHS Trust
- University of Sussex
For direct contact, visit the study record on ClinicalTrials.gov .